Fierce Pharma

SEPTEMBER 22, 2023

Merck and Eisai’s Keytruda-Lenvima tag team can’t seem to catch a break. Merck and Eisai’s Keytruda-Lenvima tag team can’t seem to catch a break.

314

314

European Pharmaceutical Review

DECEMBER 9, 2022

Tag Copenhagen A/S (Denmark). Merck KGaA (Germany). Eurofins Scientific (Germany). Ionis Pharmaceuticals, Inc. (US). LGC Limited (UK). Kaneka Corporation (Japan). Thermo Fisher Scientific, Inc. (US). Twist Bioscience Corporation (US). Maravai Life Sciences (US). Microsynth AG (Switzerland). Sarepta Therapeutics, Inc. (US).

Marketing 89

Marketing Pharmaceutical 89

Pharmaceutical Technology

FEBRUARY 10, 2023

This is not the first treatment to come with a high price tag. Undoubtedly, this has played a factor in the success of market-leading PD-1 inhibitors, Merck & Co.’s million, according to GlobalData’s Price Intelligence (POLI), making it the most expensive drug in the world.

Marketing 105

Marketing Medicine Leads Safety 105

Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Pharmaceutical 52

Pharmaceutical Leads Biopharma Medicine 52

pharmaphorum

NOVEMBER 27, 2022

Fully integrated and automated ingredient to consumer batch tracking using barcoding, RFID tagging, or IoT temperature logging and timestamping significantly reduces the chance of these mix-ups, providing complete traceability records from ingredient manufacturer to patient, and ensures the safety of the product.

Pharma 95

Pharma Safety Pharmaceutical Manufacturing 95

pharmaphorum

NOVEMBER 28, 2022

Substra is the software that powered the MELLODDY platform, a collaboration in which Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, GSK, Janssen, Merck, Novartis, and Servier all agreed to share drug discovery data — but not with each other directly, nor with Owkin.

Training 69

Training Medical Pharma Healthcare 69

European Pharmaceutical Review

NOVEMBER 10, 2022

BT-474 cell line was gene-edited to incorporate a green fluorescent protein (GFP) tag into late endosomes/lysosomes (green). An ion channel electrophysiologist by training, Martin has worked in the pharmaceutical industry for 25 years at Merck, GlaxoSmithKline and AstraZeneca. Physical characterisation.

Medicine 98

Medicine Distribution Engineering Electronics 98